Publication:

Identification of Protective Pneumococcal (T_{H}17) Antigens from the Soluble Fraction of a Killed Whole Cell Vaccine

Loading...
Thumbnail Image

Date

2012

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Moffitt, Kristin L., Richard Malley, and Ying-Jie Lu. 2012. Identification of protective pneumococcal \(T_{H}17\) antigens from the soluble fraction of a killed whole cell vaccine. PLoS ONE 7(8): e43445.

Abstract

Mucosal or parenteral immunization with a killed unencapsulated pneumococcal whole cell antigen (WCA) with an adjuvant protects mice from colonization by a (T_{H}17) CD4+ cell-mediated mechanism. Using preparative SDS gels, we separated the soluble proteins that compose the WCA in order to identify fractions that were immunogenic and protective. We screened these fractions for their ability to stimulate IL-17A secretion from splenocytes obtained from mice immunized with WCA and adjuvant. We identified 12 proteins within the stimulatory fractions by mass spectrometry; these proteins were then cloned, recombinantly expressed and purified using an Escherichia coli expression system. The ability of these proteins to induce IL-17A secretion was then evaluated by stimulation of mouse splenocytes. Of the four most stimulatory proteins, three were protective in a mouse pneumococcal serotype 6B colonization model. This work thus describes a method for identifying immunogenic proteins from the soluble fraction of pneumococcus and shows that several of the proteins identified protect mice from colonization when used as mucosal vaccines. We propose that, by providing protection against pneumococcal colonization, one or more of these proteins may serve as components of a multivalent pneumococcal vaccine.

Description

Research Data

Keywords

Biology, Microbiology, Bacterial Pathogens, Streptococci, Immunity, Immunizations, Host-Pathogen Interaction, Medicine, Clinical Immunology, Vaccination, Vaccines, Vaccine Development, Infectious Diseases, Bacterial Diseases, Pneumococcus, Infectious Disease Control, Public Health

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories